Daniel D Shoemaker is Chief Scientific Officer of FATE THERAPEUTICS INC. Currently has a direct ownership of 73,020 shares of FATE, which is worth approximately $192,772. The most recent transaction as insider was on Mar 08, 2021, when has been sold 25,000 shares (Common Stock) at a price of $82.55 per share, resulting in proceeds of $2,063,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73K
0% 3M change
0% 12M change
Total Value Held $192,772

Daniel D Shoemaker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2021
SELL
Open market or private sale
$2,063,750 $82.55 p/Share
25,000 Reduced 25.5%
73,020 Common Stock
Jan 20 2021
BUY
Grant, award, or other acquisition
-
14,411 Added 12.82%
98,020 Common Stock
Jan 11 2021
SELL
Open market or private sale
$360,042 $110.68 p/Share
3,253 Reduced 3.75%
83,609 Common Stock
Jan 08 2021
SELL
Open market or private sale
$724,620 $116.33 p/Share
6,229 Reduced 6.69%
86,862 Common Stock
Nov 16 2020
SELL
Open market or private sale
$1,286,500 $51.46 p/Share
25,000 Reduced 21.17%
93,091 Common Stock
DDS

Daniel D Shoemaker

Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on FATE

Follow FATE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE